| Literature DB >> 30365001 |
Rainiero Ávila-Polo1,2,3, Edoardo Malfatti1,4, Xavière Lornage5, Chrystel Cheraud5, Isabelle Nelson6, Juliette Nectoux7, Johann Böhm5, Raphaël Schneider5,8, Carola Hedberg-Oldfors9, Bruno Eymard4, Soledad Monges10, Fabiana Lubieniecki7,10, Guy Brochier1,6, Mai Thao Bui1, Angeline Madelaine1, Clémence Labasse, Maud Beuvin1,6, Emmanuelle Lacène1,4, Anne Boland11, Jean-François Deleuze11, Julie Thompson8, Isabelle Richard12, Ana Lía Taratuto10, Bjarne Udd13,14, France Leturcq, Gisèle Bonne, Anders Oldfors9, Jocelyn Laporte5, Norma Beatriz Romero1,6,4.
Abstract
Titin-related myopathies are heterogeneous clinical conditions associated with mutations in TTN. To define their histopathologic boundaries and try to overcome the difficulty in assessing the pathogenic role of TTN variants, we performed a thorough morphological skeletal muscle analysis including light and electron microscopy in 23 patients with different clinical phenotypes presenting pathogenic autosomal dominant or autosomal recessive (AR) mutations located in different TTN domains. We identified a consistent pattern characterized by diverse defects in oxidative staining with prominent nuclear internalization in congenital phenotypes (AR-CM) (n = 10), ± necrotic/regenerative fibers, associated with endomysial fibrosis and rimmed vacuoles (RVs) in AR early-onset Emery-Dreifuss-like (AR-ED) (n = 4) and AR adult-onset distal myopathies (n = 4), and cytoplasmic bodies (CBs) as predominant finding in hereditary myopathy with early respiratory failure (HMERF) patients (n = 5). Ultrastructurally, the most significant abnormalities, particularly in AR-CM, were multiple narrow core lesions and/or clear small areas of disorganizations affecting one or a few sarcomeres with M-band and sometimes A-band disruption and loss of thick filaments. CBs were noted in some AR-CM and associated with RVs in HMERF and some AR-ED cases. As a whole, we described recognizable histopathological patterns and structural alterations that could point toward considering the pathogenicity of TTN mutations.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30365001 DOI: 10.1093/jnen/nly095
Source DB: PubMed Journal: J Neuropathol Exp Neurol ISSN: 0022-3069 Impact factor: 3.685